California Stem Cell Inc. Files IND to Commence Phase I Clinical Trial in Spinal Muscular Atrophy
FSMA Press Release | December 1, 2010
IRVINE, Calif. (December 1, 2010) – California Stem Cell, Inc. (CSC) and Families of Spinal Muscular Atrophy (FSMA) announced today that CSC has filed an investigational new drug (IND) application with the US Food and Drug Administration (FDA) for approval to commence a Phase I safety study on a jointly-developed stem cell-derived motor neuron transplantation therapy for Spinal Muscular Atrophy (SMA) Type I.
Click HERE or on the image below to read more…
hello there and thank you for your information – I’ve certainly picked up something new from right here.
I did however expertise a few technical points using
this site, since I experienced to reload the web site many times previous
to I could get it to load correctly. I had been wondering
if your web host is OK? Not that I am complaining, but slow loading instances times will often affect your
placement in google and could damage your high quality score if ads and
marketing with Adwords. Anyway I am adding this
RSS to my e-mail and could look out for much more of
your respective exciting content. Ensure that
you update this again soon.
California Stem Cell Inc. Files IND to Commence Phase I Clinical Trial in Spinal Muscular Atrophy | SMAHeadlines.com